Jan. 1 at 8:27 PM
$SLS $IWMW $VTWG There are 100,000 AML PATIENTS IN REMISSION RIGHT NOW - who'll be benefit from and be Eligible for GPS Immunotherapy right out of the Gate.
---The Co published estimated pricing comps starting at
$280K per Patient in Year 1.
- with an Infinite Dosing Regime until Relapse.
- 5 years of Revenue Potential per Patient - the compounded Total Addressable Market is massive.
And this is Just AML remission.
$10 is NOTHING compared to what this will be.